Finland

Finland permits medical cannabis through special permits issued by FIMEA (Finnish Medicines Agency). Access is highly restricted, requiring a specialist physician to demonstrate that all conventional treatments have failed. Sativex and Bedrocan products are available through the special permit system.

Ask the Expert about Finland

Regulator

FIMEA

Key Legislation

Medicines Act

Year Legalized

N/A (special permits only)

Program Size

Very limited; special permit basis only

Key Facts

FIMEA issues special permits for cannabis medicines when all other treatments have failed
Bedrocan products and Sativex are available through the special permit system
Patients must pay the full cost — cannabis medicines are not reimbursed by KELA (social insurance)
Only a few hundred patients receive cannabis medicines annually
Finland maintains strict anti-drug policies and has no decriminalization plans

Key Legislation

Medicines Act (395/1987); Narcotics Act (373/2008)

Regulatory Body

FIMEA (Finnish Medicines Agency)

Country Info

ISO Code

Region

Europe

Tier

Tier 3 — Restricted

Status

Restricted

Sources

FIMEA

Disclaimer: This information is for general reference only and does not constitute legal advice. Cannabis regulations change frequently. Always verify with official sources and local legal counsel before making compliance decisions.